Skip to main content

Table 2 Distribution of macular edema subtype and outer retinal layer status according to the anatomical site of inflammation and their relationship with central foveal thickness and best-corrected visual acuity

From: The impact of central foveal thickness and integrity of the outer retinal layers in the visual outcome of uveitic macular edema

Type of uevitis CME (N = 74) DME (N = 59) SRF (N = 12) Status of EPIS Status of IZ
Integrity (N = 86) Disruption (N = 59) Integrity (N = 87) Disruption (N = 58)
Anterior 28 (37.84%) 23 (38.98%) 0 (0.0%) 28 (32.56%) 23 (38.98%) 27 (31.03%) 24 (41.38%)
Intermediate 22 (29.73%) 19 (32.20%) 0 (0.0%) 20 (23.26%) 21 (35.59%) 20 (22.99%) 21 (36.20%)
Posterior 15 (20.27%) 7 (11.86%) 3 (25.0%) 21 (24.42%) 4 (6.78%) 21 (24.14%) 4 (6.90%)
Panuveitis 9 (12.16%) 10 (16.96%) 9 (75.0%) 17 (19.76%) 11 (18.64%) 19 (21.84%) 9 (15.52%)
Mean CFT (mm) 460.3 ± 143.9 296.7 ± 61.4 505.8 ± 201.9 349.7 ± 125.3 467.2 ± 155.1a 352.5 ± 127.7 465 ± 155.0a
Mean BCVA (Snellen eq.) 0.63 ± 0.41 (20/80) 0.24 ± 0.33 (20/30) 0.52 ± 0.39 (20/60) 0.24 ± 0.26 (20/30) 0.77 ± 0.40a (20/125) 0.26 ± 0.28a (20/30) 0.76 ± 0.41a (20/125)
  1. CME cystoid macular edema, DME diffuse macular edema, SRF subretinal fluid accumulation, EPIS ellipsoid portion of inner segments, IZ interdigitating zone, CFT central foveal thickness, BCVA best-corrected visual acuity
  2. aStatistically significant (p < 0.001, student-t test)